Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

MIT’s Barbara Wixom, PhD, outlines the importance of data-powered research in producing financial success. 

Why Data Should Be a Top Priority

Agreement is expected to help improve the medication delivery process for patients.

ParcelShield, Triose Establish Supply Chain Visibility Partnership

Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.  

MatchRX, LSPedia Collaborate on FDA-DSCSA Compliance Solution

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

DSCSA: A Fast-Approaching Deadline

In this latest Harvard Business School Healthcare Alumni Association Q&A, Ayelet Israeli, PhD, explains the potential—as well as limitations—of these offerings and pragmatic guardrails for deployment in organizations. 

Leveraging Data for Informed Decision Making

Using AI and data science, ‘plai’ is expected to assist employees with making everyday decisions, including the manufacturing of vaccines.

Sanofi Launches New Insight-Driven App 

Biopharmas are able to industry insight to assist them across the end-to-end product lifecycle.   

Veeva Business Consulting Grows Offerings with New R&D Services

Software company’s branded orchestration platform helps to track chain of identity and chain of custody. 

Biocair Partners with Trakcel on CGT Supply Chain Visibility

While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.

Innovation in Heart Disease: A Deep Dive

The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.

Data & Technology